MeSH tree: D02.455.426.559.847
A joint research team led by KAIST has used a small, implantable neural chip to wirelessly monitor real-time changes in a neurotransmitter involved in memory and learning after an Alzheimer's drug has been administered. In ...
11 hours ago
0
4
Undeclared pharmacologically active ingredients (UPAIs) are detected in one-third of over-the-counter (OTC) skin products marketed online, according to a study published online Oct. 8 in JAMA Network Open.
Oct 15, 2026
0
11
Stopping a cancer cell from dividing does not necessarily make it harmless. Chemotherapy can leave behind living, senescent cells. These 'zombie' cells can release inflammatory signals, helping tumors resist treatment. Drugs ...
Reports that a woman employed at a plague research institute in Russia's Irkutsk region died from the disease have spiked online interest in possible treatments for the illness in North America.
Oct 9, 2026
0
4
Major depressive disorder (MDD) is a common mental health condition primarily characterized by persistent low mood or loss of interest in daily activities. While several medications are available to treat depression, finding ...
The chemotherapy agent doxorubicin is used successfully to treat a range of cancers but can, as a side effect, damage the heart muscle. Researchers at the Heidelberg Faculty of Medicine at Heidelberg University have now identified ...
Sep 21, 2026
0
7
Inside the hazard simulation lab at Iowa State University, Guowen Song watches a column of engineered smoke curl upward from a controlled burn.
Sep 10, 2026
0
6
Stopping tumor growth is only half the battle. Rather than killing tumor cells, many cancer therapies can only push them into cellular senescence, a state in which cells stop dividing but do not die. These "undead" cells ...
Aug 20, 2026
0
12
A new study reveals that the cardioprotective drug dexrazoxane significantly reduces heart damage caused by chemotherapy in pediatric cancer patients 15 years or more after treatment ends.
Aug 7, 2026
0
10
A study led by investigators at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) suggests that intensive cardiac surveillance programs routinely used for lymphoma patients with low to moderate cardiovascular ...
Jul 29, 2026
0
3
